Depression or cancer: the choice between serotonin or melatonin?

Area of Science:

• Neurobiology
• Biochemistry
• Psychiatry

Background:

• Stress impacts monoamine function, potentially causing serotonin deficiency and depression.
• Individual responses to stress vary, with some not developing depression.

Purpose of the Study:

• To explore the hypothesis that melatonin may be converted back to serotonin in individuals resistant to stress-induced depression.
• To investigate the link between lowered melatonin levels and increased cancer risk.
• To postulate the dual outcomes of unresolved stress based on personality and biochemistry.

Main Methods:

• This study is based on a hypothesis and postulates mechanisms.
• No empirical data collection or analysis is described.

Main Results:

• Individuals not developing depression under stress may have melatonin converted back to serotonin, replenishing stores.
• These individuals exhibit pleasant, unassertive traits and have lower melatonin levels.
• Lowered melatonin levels are associated with an increased risk for cancer.

Conclusions:

• Unresolved stress can result in depression (low serotonin) or cancer (low melatonin).
• Individual personality traits and biochemistry determine the outcome.
• This suggests distinct biological pathways for stress-related depression and cancer risk.